Elos Medtech appoints Managing Director in Gorlose

Report this content

Tina Friis-Poulsen has been appointed to succeed Soren Olesen in leading Elos Medtech in Gorlose, Denmark. Tina Friis-Poulsen has been with the company for more than 10 years as Quality and Regulatory Manager and has previously also been leading and responsible for Group QA/RA.

Soren Olesen will be handing over responsibility to Tina Friis-Poulsen. Soren Olesen will retain his Dental Business Director role with more focus on, among other things, strategic business development within Elos Medtech and continue reporting to CEO Jan Wahlström.

The transition of site leadership responsibilities will be implemented during the first quarter of 2021. Tina Friis-Poulsen will officially assume the position of Managing Director on April 1st, 2021.

“Tina has deep knowledge of the medical device industry, our organization, our processes and our customers," says Soren Olesen, Global Business Director Dental. "Having worked closely with Tina for many years, it´s a pleasure to hand over the management of Elos Medtech Gorlose, to such a competent person, enabling new ideas and energy, for an even more prosperous future going forward.”

By this change, we ensure a stronger focus in our Dental Business Area by leadership of Soren, where he fully can advance business opportunities, product development and our portfolio of own products.  I am happy that Tina, with her solid background, will take on as the Managing Director for our site in Gorlose as we continue our successful journey”, says Jan Wahlström, President and CEO.

Elos Medtech is a leading development and production partner for medical devices and components, with a focus on dental and orthopedic implants and instruments. The company operates from facilities in Sweden, Denmark, China and the U.S. The customer base comprises international medical technology companies.

Elos Medtech has more than 550 employees and a turnover of more than SEK 650 million. Elos Medtech has been listed on NASDAQ Stockholm AB since 1989. Elos Medtech’s B share is categorized as a Health Care company on the Small Cap list.

Gothenburg, January 15, 2021

Elos Medtech AB (publ)

For further information, please contact:

Jan Wahlström, President and CEO, +46 70-212 18 89, e-mail: jan.wahlstrom@elosmedtech.com
Soren Olesen, Global Business Director Dental, +45 40 41 28 82, e-mail: soren.olesen@elosmedtech.com


For additional information about the Elos Medtech Group, visit www.elosmedtech.com